CA2159609A1 - Factor xiii for treatment of skin wounds - Google Patents
Factor xiii for treatment of skin woundsInfo
- Publication number
- CA2159609A1 CA2159609A1 CA002159609A CA2159609A CA2159609A1 CA 2159609 A1 CA2159609 A1 CA 2159609A1 CA 002159609 A CA002159609 A CA 002159609A CA 2159609 A CA2159609 A CA 2159609A CA 2159609 A1 CA2159609 A1 CA 2159609A1
- Authority
- CA
- Canada
- Prior art keywords
- factor xiii
- treatment
- skin wounds
- skin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010072170 Skin wound Diseases 0.000 title abstract 2
- 229940012444 factor xiii Drugs 0.000 title 1
- 108010071289 Factor XIII Proteins 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000002500 effect on skin Effects 0.000 abstract 2
- 108010039627 Aprotinin Proteins 0.000 abstract 1
- 229960004405 aprotinin Drugs 0.000 abstract 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A dermal preparation for treatment of skin wounds containing as an active ingredient human blood coagulation factor XIII. This preparation may further contain aprotinin. The dermal preparation, when applied to damaged skin, especially burnt or scalded skin, can exert a superior delivery of the active ingredient, human blood coagulation factor XIII, to affected tissue, as compared with the case of intravenous administration, and can be administered without assistance of a physician.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7139593 | 1993-03-30 | ||
| JP5/71395 | 1993-03-30 | ||
| PCT/IB1994/000040 WO1994022470A1 (en) | 1993-03-30 | 1994-03-02 | Factor xiii for treatment of skin wounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2159609A1 true CA2159609A1 (en) | 1994-10-13 |
| CA2159609C CA2159609C (en) | 2007-10-16 |
Family
ID=38608929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002159609A Expired - Fee Related CA2159609C (en) | 1993-03-30 | 1994-03-02 | Factor xiii for treatment of skin wounds |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2159609C (en) |
-
1994
- 1994-03-02 CA CA002159609A patent/CA2159609C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2159609C (en) | 2007-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1214937A3 (en) | Terfenadine carboxylate and the treatment of dermal irritation | |
| CA2064039A1 (en) | Treatment to reduce edema for brain and musculature injuries | |
| WO1994017792A3 (en) | Compositions and methods for transdermal drug delivery | |
| DE69431430D1 (en) | Factor XIII for the treatment of skin wounds | |
| CA2045605A1 (en) | Treatment of leukocyte dysfunction with gm-csf | |
| CA2091134A1 (en) | Therapeutic agent for threatened abortion | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| CA2159609A1 (en) | Factor xiii for treatment of skin wounds | |
| CA2127107A1 (en) | Methods and compositions for reducing blood loss | |
| GEP20032906B (en) | Controlled Release Peroral Pharmaceutical Composition of Levosimendan for Treatment of Congestive Heart Failure | |
| TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
| Prescott | Doxil offers hope to KS sufferers | |
| EP0397211A3 (en) | Percutaneous administration of 3'-azide-3'-deoxythymidine | |
| CA2336773A1 (en) | Component b as angiogenic agent in combination with human growth factors | |
| RU2003344C1 (en) | Method for burn disease treatment | |
| US20190209639A1 (en) | Ointment for burn | |
| Kharitonov et al. | Treatment of suppurative wounds of soft tissues with colocyl and its combination with proteolytic enzymes | |
| Di Prima et al. | Clinical and bacteriological evaluation of ofloxacin in 20 cases of skin infection. | |
| Krizek | Wound and reconstructive problems in advanced disease | |
| CN1112428A (en) | Medicament for burn and scald | |
| RU97121508A (en) | METHOD OF EMERGENCY EMERGENCY ASSISTANCE IN LONG-TERM COMPRESSION INJURY OF THE EXTREMITY | |
| WO1994008474A3 (en) | Medical food and method of administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20130304 |